Response to Alpha-Interferon Treatment of the Congenital Dyserythropoietic Anemia type I in Two Sicilian Beta Thalassemia Carriers
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yarali N, Fişgin T, Duru F, Atilla P, Müftüoğlu SF, Kaymaz SF (2005) Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child. Pediatr Hematol Oncol 22(4):265–270
Dgany O, Avidan N, Delaunay J, Krasnov T, Shalmon L, Shalev H, Eidelitz-Markus T, Kapelushnik J, Cattan D, Pariente A, Tulliez M, Crétien A, Schischmanoff PO, Iolascon A, Fibach E, Koren A, Rössler J, Le Merrer M, Yaniv I, Zaizov R, Ben-Asher E, Olender T, Lancet D, Beckmann JS, Tamary H (2002) Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet 71(6):1467–1474
Lavabre-Bertrand T, Blanc P, Navarro R, Saghroun M, Vannereau H, Braun M, Wagner A, Taïb J, Lavabre-Bertrand C, Navarro M (1995) Alpha-Interferon therapy for congenital dyserythropoiesis type I. Br J Haematol 89(4):929–932
Babbs C, Roberts NA, Sanchez-Pulido L, McGowan SJ, Ahmed MR, Brown JM, Sabry MA, WGS500 Consortium, Bentley DR, Mc Vean GA, Donnelly P, Gileadi O, Ponting CP, Higgs DR, Buckle VJ (2013) Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. Haematologica 98(9):1383–1387